Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Chen‐Xi Yin"'
Autor:
Wen‐Zhuo He, Lei Wang, Chen‐Xi Yin, Jia‐Hong Yi, Ya‐Nan Jin, Chang Jiang, Gui‐Fang Guo, Liang‐Ping Xia
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 6488-6498 (2023)
Abstract Background Although the use of regorafenib plus nivolumab demonstrates promising outcomes in patients with refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC), this effect has not been substantiated in other studies. M
Externí odkaz:
https://doaj.org/article/c1e64d264da14961962baf3349ed191c
Autor:
Wen-Zhuo He, Yu-Ming Rong, Chang Jiang, Fang-Xin Liao, Chen-Xi Yin, Gui-Fang Guo, Hui-Juan Qiu, Bei Zhang, Liang-Ping Xia
Publikováno v:
Chinese Journal of Cancer, Vol 35, Iss 1, Pp 1-8 (2016)
Abstract Background It remains controversial whether palliative primary tumor resection (PPTR) can provide survival benefits to the patients with metastatic colorectal cancer (mCRC) who have unresectable metastases. The aim of this study was to evalu
Externí odkaz:
https://doaj.org/article/16a89ab28a3043139e48f38352ff38f3
Autor:
Fang Wang, Gui-fang Guo, Hui-juan Qiu, Wen-zhuo He, Fei-fei Zhou, Xu-xian Chen, Pi-li Hu, Bei Zhang, Chen-xi Yin, Li Zhang, Liang-ping Xia
Publikováno v:
Cancer Biology & Medicine, Vol 9, Iss 1, Pp 38-43 (2012)
Objective The standard therapy after failure of the initial non-first line epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment in advanced non-small cell lung cancer (NSCLC) has not yet been established. The aim of the cur
Externí odkaz:
https://doaj.org/article/f4e36b10ce6a4ab6b437f7ecd47c1338
Publikováno v:
Environmental Science and Pollution Research. 30:49180-49196
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::daec9258f55586a8d2441c61c9b0a0fc
https://doi.org/10.1007/s11356-023-25713-2
https://doi.org/10.1007/s11356-023-25713-2
Autor:
Wen‐Zhuo He, Lei Wang, Chen‐Xi Yin, Jia‐Hong Yi, Ya‐Nan Jin, Chang Jiang, Gui‐Fang Guo, Liang‐Ping Xia
Publikováno v:
Cancer Medicine. 12:6488-6498
Purpose Although the use of regorafenib plus nivolumab demonstrates promising outcomes in patients with refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC), other studies failed to observe such an effect. In addition, a compari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d57342f11429cc9abf849e03ede94cc
https://doi.org/10.1002/cam4.5417
https://doi.org/10.1002/cam4.5417
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fang, Wang, Gui-Fang, Guo, Hui-Juan, Qiu, Wen-Zhuo, He, Fei-Fei, Zhou, Xu-Xian, Chen, Pi-Li, Hu, Bei, Zhang, Chen-Xi, Yin, Li, Zhang, Liang-Ping, Xia
Publikováno v:
Cancer Biology & Medicine
Objective The standard therapy after failure of the initial non-first line epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment in advanced non-small cell lung cancer (NSCLC) has not yet been established. The aim of the cur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2deffa86e996e6280a7459b9e70ae324
https://pubmed.ncbi.nlm.nih.gov/23691453
https://pubmed.ncbi.nlm.nih.gov/23691453
Autor:
Chang Jiang, Wan-Ming Hu, Fang-Xin Liao, Qiong Yang, Ping Chen, Yu-Ming Rong, Gui-Fang Guo, Chen-Xi Yin, Bei Zhang, Wen-Zhuo He, Liang-Ping Xia
Publikováno v:
OncoTargets & Therapy; Feb2016, Vol. 9, p877-883, 7p
Publikováno v:
Photochemistry & Photobiology; Sep1993, Vol. 58 Issue 3, p425-431, 7p